Bosniak II cyst is a minimally complicated renal cyst, positioned between simple cyst (Bosniak I) and suspicious cyst (Bosniak IIF). According to the 2019 updated Bosniak classification, it may show few thin septa (1-3, ≤2 mm thickness), thin and short-segment calcification (any type — septal, wall, or nodular), hyperdense cyst content (≥70 HU on non-contrast CT, ≤3 cm), or non-enhancing septa/wall thickening — but no measurable enhancement. Malignancy risk is <5% (practically <1%), requiring no follow-up or surgery. Common in the population and incidentally detected. Constitutes 40-60% of all renal cystic lesions. Important clinical point: Bosniak II cysts are considered benign and require no follow-up — therefore 'too small to characterize' (≤3 cm hyperdense) cysts are also included in this category.
Age Range
30-85
Peak Age
55
Gender
Equal
Prevalence
Common
Bosniak II cysts share the tubular epithelial origin mechanism of simple renal cysts but additional pathological processes add minimal complication. Thin septa result from incorporation of adjacent tubular structures into the cyst cavity during development or formation of fibrous bands within the cavity — these septa are not vascularized and show no enhancement. Thin calcifications represent dystrophic calcification deposition in the cyst wall or septa — formed by precipitation of calcium salts during healing of chronic inflammation or hemorrhage. On imaging, calcifications appear as very high density/hypointensity (calcium's high atomic number → very high X-ray absorption). Hyperdense cyst content (≥70 HU) results from accumulation of denatured protein and hemoglobin degradation products from prior intracystic hemorrhage — this proteinaceous material increases X-ray attenuation and shortens T1 relaxation time (T1 hyperintensity). Importantly, all these changes occur in avascular structures — no vascular proliferation exists, therefore no enhancement occurs and there is no malignant potential.
Absence of enhancement (pre/post <10 HU difference) in the presence of minimal complications such as few thin septa (1-3, ≤2 mm), thin calcification, or hyperdense content (≥70 HU, ≤3 cm) is the defining criterion of Bosniak II. This combination is considered benign with <5% malignancy risk and requires no follow-up. Detection of enhancement immediately upgrades to Bosniak III-IV.
1-3 thin septa (≤2 mm thickness) may be visible within the cyst cavity on non-contrast CT. Septa have smooth contour, are thin and homogeneous density. Septa show no measurable enhancement in contrast phases (<10 HU increase). In the 2019 Bosniak update, 1-3 septa are classified as Bosniak II, 4+ as Bosniak IIF. Septal thickness ≤2 mm is Bosniak II, 3 mm is Bosniak IIF, ≥4 mm is evaluated toward Bosniak III. These criteria should be interpreted as a continuous spectrum rather than rigid categories.
Report Sentence
Few (1-3) thin septa (≤2 mm) are seen in the cystic lesion in the kidney without enhancement; consistent with Bosniak category II, no follow-up required.
Fine calcification in cyst wall or septa. Calcification pattern may vary: thin linear (along wall), punctate (focal), or scattered on septa. In the 2019 Bosniak update, calcification type (thin vs. thick) no longer determines Bosniak classification alone — evaluated together with enhancement presence/absence. Thin calcification + no enhancement = Bosniak II. Even thick nodular calcification may remain Bosniak II if no enhancement. Calcification appears as very high density on CT (>100 HU), markedly hypointense (signal void) on MRI T1/T2.
Report Sentence
Fine calcification in the cyst wall/septum without enhancement; consistent with Bosniak II criteria.
Homogeneous hyperdense cyst content showing ≥70 HU density on non-contrast CT. In the 2019 Bosniak update, hyperdense cysts ≤3 cm are classified as Bosniak II. Hyperdense content is due to prior intracystic hemorrhage (denatured hemoglobin, proteinaceous material). Shows no enhancement in contrast phases (pre/post density difference <10 HU). Hyperdense cysts >3 cm are classified as Bosniak IIF (follow-up required). On MRI, T1 hyperintense (proteinaceous/hemorrhagic material → T1 shortening), generally hyperintense on T2 but slightly lower signal than simple cyst (protein → T2 shortening).
Report Sentence
Hyperdense cyst measuring __ mm with __ HU density in the kidney on non-contrast CT, showing no enhancement in contrast phases; consistent with Bosniak II hyperdense cyst, no follow-up required.
Hyperintense signal on T1-weighted images, different from simple cyst — reflects proteinaceous or hemorrhagic content. Signal is homogeneous and evenly distributed throughout the cyst. Signal persists on fat-sat T1 (protein, not fat). No enhancement on post-contrast subtraction images (no pre-post difference). T1 subtraction technique is important for diagnosing hyperdense cyst on MRI — precontrast T1 hyperintensity may be confused with post-contrast enhancement.
Report Sentence
T1 hyperintense cyst on MRI with absence of enhancement confirmed on subtraction images; consistent with Bosniak II cyst with proteinaceous/hemorrhagic content.
Thin septa within the cyst cavity on B-mode ultrasound — visible as echogenic thin linear bands. Septa have smooth contour and are thin (≤2 mm). No vascularity in septa or wall on Doppler (avascular). Cyst content may be anechoic or show low-level internal echoes (proteinaceous content). Posterior acoustic enhancement is preserved. Hyperdense cysts may appear as hyperechoic cysts on US but differentiation from solid lesion may be difficult — CT/MRI confirmation is needed.
Report Sentence
Thin septa seen within the cyst in the kidney on US without vascularity on Doppler; consistent with Bosniak II minimally complicated cyst.
Hyperintense cyst on T2-weighted images — similar to simple cyst but thin septa (hypointense linear structures on T2) may be visible. In proteinaceous cysts, T2 signal may be slightly lower than simple cyst (protein-T2 shortening effect). Hyperdense cysts show variable T2 signal: high protein → lower T2, low protein → near simple cyst T2. Signal persists on fat-sat T2 (not fat).
Report Sentence
Thin septa within hyperintense cyst on MRI T2, consistent with Bosniak II together with absence of enhancement.
Criteria
1-3 thin septa (≤2 mm), no enhancement, water-density fluid.
Distinct Features
Most common Bosniak II subtype. Easily recognized on US. Septa are very thin and smooth-contoured on contrast CT.
Criteria
≥70 HU on non-contrast CT, ≤3 cm size, homogeneous, no enhancement.
Distinct Features
T1 hyperintense on MRI (subtraction confirms absence of enhancement). Upgrades to Bosniak IIF if >3 cm (follow-up required). May mimic solid mass on CT — MRI subtraction resolves.
Criteria
Thin calcification (wall or septa), any type, no enhancement.
Distinct Features
In 2019 update, calcification thickness no longer determines Bosniak class alone — evaluated with enhancement status. Even thick calcification may remain Bosniak II if no enhancement.
Distinguishing Feature
Simple cyst (Bosniak I) shows no internal structure — no septa, calcification, or hyperdense content, imperceptible wall. Bosniak II may show few septa, thin calcification, or hyperdense content. Neither shows enhancement and no follow-up is needed.
Distinguishing Feature
Bosniak IIF may have ≥4 septa, 3 mm septal thickness, or hyperdense cyst >3 cm. Minimal enhancement suspicion may exist. IIF requires follow-up (annual CT/MRI 5 years), II does not. Malignancy risk: II <5%, IIF 5-15%.
Distinguishing Feature
Bosniak III has thick or enhancing septa (≥4 mm) and/or wall thickening. Measurable enhancement is present. Malignancy risk 40-60%. Surgical exploration is recommended. Bosniak II has absolutely no enhancement.
Distinguishing Feature
Cystic RCC shows solid enhancing component, thick irregular septa, and wall nodules — Bosniak IV. Marked enhancement present. DWI restriction in solid component. Bosniak II has absolutely no solid component or enhancement.
Urgency
routineManagement
conservativeBiopsy
Not NeededFollow-up
no-follow-upBosniak II cysts are considered benign and require no follow-up — the 2019 Bosniak update has reinforced this approach. Malignancy risk is <5% (practically <1%), not warranting surgical intervention with high false-positive rate. Reporting: Bosniak II cyst is described with 'no follow-up required' note. Bosniak class and management recommendation should be clearly communicated to clinician. Points of attention: (1) if septa number or thickness is borderline II-IIF, classifying as IIF and recommending follow-up is safer, (2) hyperdense cyst >3 cm upgrades to Bosniak IIF — follow-up required, (3) subtraction technique is mandatory for hyperdense cyst evaluation on MRI — precontrast T1 hyperintensity may mimic enhancement. Complications are rare: in case of infection or hemorrhage, cyst size and morphology may change — confirmation with follow-up CT/MRI may be needed.
Bosniak II cysts are benign and require no follow-up. Malignancy risk is negligible. There is no indication for surgery or biopsy.